Search results for: children act pediatric trials

Best Pharmaceuticals for Children Act (BPCA) Pediatric Trials Network (PTN)

Although the primary focus of this Contract is to support the Best Pharmaceuticals for Children Act-Pediatric Trials Network clinical activities, NICHD also anticipates the need to utilize this Contract to acquire similar types of support for other NICHD pediatric drug development activities.BPCA 2017 authorizes NICHD to identify therapeutic gaps in pediatrics, which are pediatric diseases, disorders or conditions where more complete knowledge and

and management services in support of ongoing BPCA Phase 1-3 pediatric clinical trial activities. 

for the pediatric clinical trials, and select preclinical data conducted under the authority of the Best Pharmaceuticals for Children Act (BPCA).

patient base in the U.S., United Kingdom, and Peru at time of award for the implementation of a natural history study of AFM protocol and have documented experience collaborating in multicenter infectious disease clinical studies or trials;2) Documented experience in successfully enrolling large multinational natural history studies or clinical trials in hospitalized pediatric patients with rare or emerging viral diseases;3) Documented evidence of